ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 641052 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 641052; 2) Community: the network communities that were significantly associated with the response to NSC 641052; 3) Molecule: the relationships between components within communities and NSC 641052; 4) MDR: the compounds that were significantly associated with the NSC 641052.

NSC Compound Enrichment Correlation
NSC 676914 2-(4-((4-amino-2-methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acid 0.0303322639291198 0.38738113
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0303322639291198 0.81208833
NSC 682764 Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- 0.0303322639291198 -0.078113227
NSC 690270 ANTINEOPLASTIC-690270 0.0303322639291198 0.5452891
NSC 693986 Pyrimidine-2,4(1H,3H)-dione, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-5-methyl-3-propynyl-, (E)-, 0.0303322639291198 0.5744156
NSC 700122 Null 0.0303322639291198 0.5769519
NSC 700657 Trapoxin B 0.0303322639291198 0.31289308
NSC 701373 3-Pyridinecarbonitrile, 6-[4-[(7-chloro-4-quinolinyl)amino]phenyl]-1,2-dihydro- 4-(4-methoxy-1-naphthalenyl)-2-oxo- 0.0303322639291198 0.45219367
NSC 701378 3-Pyridinecarbonitrile, 4-(4-chlorophenyl)- 6-[4-[[7-(trifluoromethyl)-4-quinolinyl]amino]phenyl]- 1,2-dihydro-2-oxo- 0.0303322639291198 0.40510219
NSC 702400 Null 0.0303322639291198 0.16310649
Total:79  Current:53    [First] [Prev] [Next] [Last]